Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers

The requested reference [07725c1feb5b1c52657faabc92b93a3e02fc0d49] no longer exists in our database. It has been replaced by the current reference: [6afaaeb805a0e7e0fd77b2070dc8bf22f379f400]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CVN766 in Healthy Subjects
Epistemonikos ID: 90e09cf5286bd0b7ba40d2742a87c4a0d7a3d7fa
First added on: May 09, 2024